APA (7th ed.) Citation

JG, S., G, S., P, E., JA, S., KA, A., DE, O., . . . JF, T. (2021). Pan-cancer prediction of radiotherapy benefit using genomic-adjusted radiation dose (GARD): A cohort-based pooled analysis. The Lancet. Oncology, 22(9), 1221. https://doi.org/10.1016/S1470-2045(21)00347-8

Chicago Style (17th ed.) Citation

JG, Scott, Sedor G, Ellsworth P, Scarborough JA, Ahmed KA, Oliver DE, Eschrich SA, Kattan MW, and Torres-Roca JF. "Pan-cancer Prediction of Radiotherapy Benefit Using Genomic-adjusted Radiation Dose (GARD): A Cohort-based Pooled Analysis." The Lancet. Oncology 22, no. 9 (2021): 1221. https://doi.org/10.1016/S1470-2045(21)00347-8.

MLA (9th ed.) Citation

JG, Scott, et al. "Pan-cancer Prediction of Radiotherapy Benefit Using Genomic-adjusted Radiation Dose (GARD): A Cohort-based Pooled Analysis." The Lancet. Oncology, vol. 22, no. 9, 2021, p. 1221, https://doi.org/10.1016/S1470-2045(21)00347-8.